143 related articles for article (PubMed ID: 2904532)
1. Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes.
Kronsbein P; Jörgens V; Mühlhauser I; Scholz V; Venhaus A; Berger M
Lancet; 1988 Dec; 2(8625):1407-11. PubMed ID: 2904532
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria.
Pieber TR; Holler A; Siebenhofer A; Brunner GA; Semlitsch B; Schattenberg S; Zapotoczky H; Rainer W; Krejs GJ
Diabet Med; 1995 Apr; 12(4):349-54. PubMed ID: 7600753
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effectiveness of an ambulatory teaching/treatment programme for non-insulin dependent (type 2) diabetic patients.
Domenech MI; Assad D; Mazzei ME; Kronsbein P; Gagliardino JJ
Acta Diabetol; 1995 Oct; 32(3):143-7. PubMed ID: 8590781
[TBL] [Abstract][Full Text] [Related]
4. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
[TBL] [Abstract][Full Text] [Related]
5. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
Wolffenbuttel BH; Weber RF; Weeks L; van Koetsveld PM; Verschoor L
Diabetes Res; 1990 Feb; 13(2):79-84. PubMed ID: 2091874
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR;
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308
[TBL] [Abstract][Full Text] [Related]
8. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.
Davies MJ; Heller S; Skinner TC; Campbell MJ; Carey ME; Cradock S; Dallosso HM; Daly H; Doherty Y; Eaton S; Fox C; Oliver L; Rantell K; Rayman G; Khunti K;
BMJ; 2008 Mar; 336(7642):491-5. PubMed ID: 18276664
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas.
Scott AR; Attenborough Y; Peacock I; Fletcher E; Jeffcoate WJ; Tattersall RB
BMJ; 1988 Sep; 297(6650):707-10. PubMed ID: 2852514
[TBL] [Abstract][Full Text] [Related]
11. Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.
Hershon KS; Hershon PM
Endocr Pract; 2000; 6(1):20-5. PubMed ID: 11419922
[TBL] [Abstract][Full Text] [Related]
12. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
BMJ; 1995 Jan; 310(6972):83-8. PubMed ID: 7833731
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
[TBL] [Abstract][Full Text] [Related]
14. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
[TBL] [Abstract][Full Text] [Related]
15. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education.
Chan WB; Chan JC; Chow CC; Yeung VT; So WY; Li JK; Ko GT; Ma RC; Cockram CS
QJM; 2000 Mar; 93(3):183-90. PubMed ID: 10751238
[TBL] [Abstract][Full Text] [Related]
16. UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group.
Diabetes Care; 1998 Jan; 21(1):87-92. PubMed ID: 9538975
[TBL] [Abstract][Full Text] [Related]
17. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
19. The effect of functional insulin therapy on glycaemic parameters in children with diabetes mellitus type 1.
Štimjanin-Koldžo D; Alajbegović S; Štimjanin E; Mehinagić J
Med Glas (Zenica); 2017 Aug; 14(2):164-168. PubMed ID: 28698534
[TBL] [Abstract][Full Text] [Related]
20. Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting.
Kuniss N; Müller UA; Kloos C; Müller R; Starrach G; Jörgens V; Kramer G
Acta Diabetol; 2018 Feb; 55(2):131-137. PubMed ID: 29149381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
